Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
coronary artery disease
MedTech
Heartflow's updated coronary plaque AI nets FDA clearance
Described as the next generation of its platform, the software offers 3D, color-coded visualizations that quantify plaque blockages.
Conor Hale
Sep 24, 2025 12:00pm
Heartflow pumps up IPO plans to $300M
Aug 6, 2025 11:20am
Orchestra BioMed scores $111M, backed by Medtronic, Ligand
Aug 5, 2025 3:41pm
Coronary AI diagnostic developer Heartflow files $100M IPO
Jul 18, 2025 11:43am
J&J trials IVL-first strategy in women with blocked coronaries
May 20, 2025 11:45am
J&J's Shockwave to test Javelin lithotripsy in coronary arteries
Apr 7, 2025 10:50am
